Registry of Lobbyists

Monthly Communication Reports in: May 2022

Other options for searching the Registry: 12-Month Lobbying Activity Search; Advanced Registry Search; Recent Registrations; and Recent Monthly Communication Reports.

The list below is sorted by communication date, beginning with the most recent.

Hoffmann-La Roche Limited

RONNIE MILLER, PRESIDENT AND CHIEF EXECUTIVE OFFICER (Corporation)

Results 1-6 of 6

  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sébastien Aubertin-Giguère, Assistant Deputy Minister | Covid-19 Task Force | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2022-05-31
    Posted date: 2022-06-11
    Communication number: 64-533867 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Stephen Ellis, Member of Parliament | House of Commons
    • Adam Van Koeverden, Member of Parliament | House of Commons
    • Jamie Kippen, Chief of Staff | Minister's Office | Health Canada (HC)
    • Jean-Sebastien Boch, Director of Policy for the Minster of Health | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2022-05-31
    Posted date: 2022-06-11
    Communication number: 64-533870 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Eric Costen, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    • Darryl Patterson, Director General | Innovation, Science and Economic Development Canada (ISED)
    • Kasondra White, Director of Strategy | Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    • Michelle Boudreau, Executive Director | Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Tom Kmiec, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2022-05-30
    Posted date: 2022-06-11
    Communication number: 64-533869 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sébastien Aubertin-Giguère, Assistant Deputy Minister | Covid-19 Task Force | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2022-05-26
    Posted date: 2022-06-11
    Communication number: 64-533866 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Carol Hughes, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2022-05-17
    Posted date: 2022-06-11
    Communication number: 64-533868 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sébastien Aubertin-Giguère, Assistant Deputy Minister | Covid-19 Task Force | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2022-05-13
    Posted date: 2022-06-11
    Communication number: 64-533865 View associated registration

Return to Monthly Communication Reports by Reporting Period

Date Modified: